DUBLIN, March 21, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/bzc2fs/global_cancer) has announced the addition of the "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The Global Cancer Monoclonal Antibody Partnering 2010-2016: Deal trends, players, financials and forecasts report provides an understanding and access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all Cancer monoclonal antibody partnering deals announced since Jan 2010, including financial terms where available, including links to online deal records of actual Cancer monoclonal antibody partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
This report provides details of the latest antibody agreements announced in the healthcare sectors, covering:
In Cancer Monoclonal Antibody Partnering Terms & Agreements, the available deals are listed by:
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Cancer monoclonal antibody dealmaking
Chapter 3 - Leading Cancer monoclonal antibody deals
Chapter 4 - Most active Cancer monoclonal antibody dealmakers
Chapter 5 - Cancer monoclonal antibody contracts dealmaking directory
Chapter 6 - Cancer monoclonal antibody dealmaking by technology type
Chapter 7 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/bzc2fs/global_cancer
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article